Cargando…

Serums and Vaccines in Influenza

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Red Cross Society in France for the Medical Officers of the American Expeditionary Forces, 1918-1919 1919
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211116/ https://www.ncbi.nlm.nih.gov/pubmed/37757231

Ejemplares similares

2743. Safety of Recombinant Influenza Vaccine Compared with Inactivated Influenza Vaccine in Adults
por: Hansen, John, et al.
Publicado: (2019)

990. Impact of Influenza Vaccination Setting on Timing of Vaccination in a National Sample of Influenza-Vaccinated Adults
por: Luther, Megan
Publicado: (2018)

Use of Convalescent Human Serum in Influenza Pneumonia
Publicado: (1919)

LB20. Impact of School-Located Influenza Vaccination on Vaccination Coverage, School Absenteeism, and Influenza Hospitalization
por: Benjamin-Chung, Jade
Publicado: (2018)

1168. Cost-effectiveness of high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccine for older people in a country with high influenza vaccination rate
por: Nham, Eliel, et al.
Publicado: (2023)

2322. Effectiveness of Recombinant Influenza Vaccine vs. Standard Dose Inactivated Influenza Vaccines Against Hospitalized Influenza-Related Outcomes in Adults: A Cluster Randomized Trial
por: Hsiao, Amber, et al.
Publicado: (2022)

Safety of Influenza Vaccination Among Hospitalized Patients
por: Tartof, Sara, et al.
Publicado: (2017)

LB15. Vaccine Effectiveness of Flucelvax Relative to Inactivated Influenza Vaccine During the 2017–18 Influenza Season in Northern California
por: Klein, Nicola P, et al.
Publicado: (2018)

2739. Comparison of Hemagglutination Antibody Inhibition (HAI) Titers Following Influenza Vaccination by Birth Cohort and Repeated Influenza Vaccination History
por: Sherman, Amy C, et al.
Publicado: (2019)

1162. Influenza Vaccination Among Pregnant People in the Vaccine Safety Datalink, 2016-17 through 2022-23 Influenza Seasons
por: Irving, Stephanie, et al.
Publicado: (2023)

1012. Protective Effects of Maternal Influenza Vaccine during Pregnancy and Breastfeeding on Risk of Infant Influenza
por: Rick, Anne-Marie, et al.
Publicado: (2023)

Efficacy of Influenza and Pneumococcal Vaccination in Preventing COPD Exacerbation
por: Haque, Azharul, et al.
Publicado: (2017)

Influenza vaccination in pediatric age
por: Esposito, Susanna, et al.
Publicado: (2015)

2746. Effectiveness of Influenza Vaccine for Prevention of Influenza-associated Hospitalizations Among Immunocompromised Adults—2017–2018
por: Silveira, Fernanda P, et al.
Publicado: (2019)

1435. The Cost-Effectiveness of Vaccinating With an Adjuvanted Trivalent Influenza Vaccine for the 65+ Population in Argentina
por: Nguyen, Van, et al.
Publicado: (2018)

Older adults’ vaccine hesitancy: psychosocial predictors of influenza, pneumococcal, & shingles vaccine uptake
por: Nicholls, Louise Brown, et al.
Publicado: (2020)

Influenza Vaccination and Treatment with Antiviral Agents Among Hospitalized Adults in the 2014–2015 and 2015–2016 Influenza Seasons
por: E Segaloff, Hannah, et al.
Publicado: (2017)

1161. Effectiveness of the Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Infections in Outpatient Immunocompromised Adults, 2017-2018
por: Kramer, Kailey Hughes, et al.
Publicado: (2023)

2737. Comparison of Antibody Responses to Vaccination with a Pure Hemagglutinin Influenza Vaccine (rHA) and Licensed Subvirion Influenza Vaccine Made in Eggs or Cell Culture in Adults 60 Years and Older
por: Sarker, Moumita, et al.
Publicado: (2019)

2747. Relative Vaccine Efficacy of High-Dose vs. Standard Dose Influenza Vaccines in Preventing Probable Influenza in a US Medicare Fee-for-Service Population
por: Paudel, Misti, et al.
Publicado: (2019)

1789. Comparison of influenza vaccine effectiveness estimates from the US Influenza Vaccine Effectiveness Network and Electronic Health Record Source Population Data, 2021-2022
por: McLean, Callie, et al.
Publicado: (2023)

2800. Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED): Influenza-Like-Illness Rates in Year 1
por: Schofield, Christina, et al.
Publicado: (2019)

REAL-WORLD EFFECTIVENESS ENHANCED INFLUENZA VACCINES IN OLDER ADULTS DURING THREE CONSECUTIVE INFLUENZA SEASONS: 2017–2020
por: McGovern, Ian
Publicado: (2022)

2731. Does Last Season’s Influenza Vaccination Affect Current Season’s Vaccine Effectiveness in Young Children?
por: Rao, Suchitra, et al.
Publicado: (2019)

2361. Prevalence of Zoster Infection Post mRNA COVID-19 Vaccination Compared to Influenza Vaccination
por: Lazbin, Mark S, et al.
Publicado: (2023)

1941. Coadministration of Bivalent Respiratory Syncytial Virus (RSVpreF) Vaccine With Influenza Vaccine in Older Adults
por: Baber, James A, et al.
Publicado: (2023)

Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season
por: Flannery, Brendan, et al.
Publicado: (2017)

997. Protection of Unvaccinated Individuals by Influenza Vaccine Coverage of Household Contacts
por: Malosh, Ryan E, et al.
Publicado: (2018)

Potential Sources of Racial and Ethnic Disparities in Nursing Home Influenza Vaccination
por: Riester, Melissa, et al.
Publicado: (2021)

1934. Association between Receipt of COVID-19, Influenza, and Pneumococcal Vaccination
por: Choi, Chris, et al.
Publicado: (2022)

29. Impact of Enhanced Influenza Vaccines on Direct Healthcare Costs for the U.S. Elderly: A Comprehensive Real-World Evaluation of Adjuvanted Trivalent Influenza Vaccine Compared to Trivalent High-Dose Influenza Vaccine for the 2018–19 Influenza Season
por: Postma, Maarten, et al.
Publicado: (2020)

372. Co-Administration of OVX836, NP-Based Universal Influenza Vaccine Candidate, with Conventional HA-Based Influenza Vaccine: Results of Phase 2a Clinical trial
por: Willems, Paul, et al.
Publicado: (2023)

1163. Influenza Vaccination Coverage through December among Persons Ages Six Months and Older in the Vaccine Safety Datalink, 2017-18 through 2022-23 Influenza Seasons
por: Irving, Stephanie, et al.
Publicado: (2023)

995. Effectiveness of Influenza Vaccine for Prevention of Influenza-Associated Hospitalizations Among High-Risk Adults in the United States, 2015–2016
por: Alyanak, Elif, et al.
Publicado: (2018)

2741. Seasonal Influenza Vaccine Timing in Children and Adults Hospitalized with Influenza in the United States, FluSurv-NET, 2013–2017
por: Haston, Julia C, et al.
Publicado: (2019)

1733. Effectiveness of Influenza Vaccination Against Influenza-Associated Emergency Department (ED) Visits and Hospitalizations Among Children With and Without Underlying Medical Conditions, New Vaccine Surveillance Network (NVSN), 2015-2016 through 2019-2020 Influenza Seasons
por: Noble, Emma K, et al.
Publicado: (2023)

2659. Substantially Elevated Influenza Risk in Vaccinated Immunocompromised Adults and High-Risk Patients Relative to All Vaccinated
por: Zemlianskaia, Natalia, et al.
Publicado: (2023)

662 Missed opportunities for influenza vaccination among inpatients with influenza
por: Rao, Suchitra, et al.
Publicado: (2014)

Influenza Vaccine Effectiveness Against Influenza-Associated Pneumonia and Pneumococcal Pneumonia in Older Adults: A Prospective Test-Negative Design Study
por: Suzuki, Motoi, et al.
Publicado: (2017)

2638. Patterning of high-risk comorbidity associated with vaccination but not influenza status among hospitalized patients in an influenza test-negative design cohort
por: Leis, Aleda M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uud06j4lqm11tid8fsrj47l8vs